Precipio releases year-end 2021 preliminary unaudited results and outlook for 2022

New haven, conn., feb. 24, 2022 (globe newswire) -- specialty cancer diagnostics company precipio, inc. (nasdaq: prpo) , today announced its unaudited and preliminary results for 2021. the company anticipates posting revenues of $8.9 million, an increase of $2.8 million from 2020, representing a 45% year-over-year increase. additionally, preliminary q4-2021 revenues of $2.4 million represent a 25% increase from revenues of $1.9 million in q4-2020.
PRPO Ratings Summary
PRPO Quant Ranking